This review summarizes the detrimental effects of cigarette and noncigarette emission exposure on autonomic function, with particular emphasis on the mechanisms of acute and chronic modulation of the sympathetic nervous system. We propose that the nicotine and fine particulate matter in tobacco smoke lead to increased sympathetic nerve activity, which becomes persistent via a positive feedback loop between sympathetic nerve activity and reactive oxidative species. Furthermore, we propose that baroreflex suppression of sympathetic activation is attenuated in habitual smokers; that is, the baroreflex plays a permissive role, allowing sympathoexcitation to occur without restraint in the setting of increased pressor response. This model is also applicable to other nontobacco cigarette emission exposures Although many of the potential mechanisms by which smoking dramatically increases cardiac risk and mortality, including adverse effects on platelets and endothelium, and increased inflammation and oxidative stress were recently comprehensively reviewed (3), the effects of tobacco exposure on the autonomic nervous system were not. The autonomic nervous system is composed of afferent nerve fibers located throughout the body, including the lungs, heart, and vasculature. These afferent nerve fibers are sensitive to both mechanical and metabolic From the
Strong evidence supports the concept that smoking alters the balance of the autonomic nervous system, and specifically, that tobacco smoke exposure leads to a predominance of sympathetic nerve activity (SNA). Cigarette smoking increases the risk for atrial and ventricular arrhythmias (4, 5) , sudden death (1), and acute myocardial infarction and causes hemodynamic changes that exacerbate heart failure (6), and increased SNA contributes to all of these complications ( Table 1) .
We will review the evidence that: 1) nicotine, with a contribution from fine particulate matter (PM 2.5 ; defined as <2.5 mm in hydrodynamic diameter), underlies the acute sympathoexcitatory effects of tobacco smoke, which are opposed by intact arterial baroreflexes; 2) PM 2.5 in tobacco smoke generates reactive oxygen species and inflammation, which play a crucial role in sustained sympathetic activation; baroreflexes are blunted in habitual smokers, and, therefore, play a permissive role; and 3) this proposed model, integrating a positive feedback loop between SNA and reactive oxygen species/inflammation, and a blunted negative feedback loop between SNA and the baroreflex, is potentially shared by other toxic emission sources, including marijuana, e-cigarettes, waterpipes, and air pollution. Details of the PubMed search and additional references and discussion are available in the Online Appendix.
EVIDENCE THAT ACUTE AND LONG-TERM TOBACCO SMOKE EXPOSURE INCREASES SNA
ACUTE EXPOSURE. Tobacco smoke is composed of gases and PM 2.5 , consisting of over 4,000 identified potential toxicants, including nicotine. Because nicotinic acetylcholine receptors are present in the central nervous system, autonomic ganglia, and at the neuromuscular junction, early investigations of the neurovascular effects of tobacco focused on the acute effects of nicotine, which play an important role in its interactions with the autonomic nervous system. Acutely, nicotine causes the local release of catecholamines from adrenergic nerve terminals (7, 8) . In humans, nicotine exposure through smoking or intravenous nicotine administration leads to an acute increase in blood pressure and heart rate, peaking within 5 to 10 min of exposure (9, 10) .
Although plasma nicotine levels continue to rise with increased exposure, nicotine tolerance develops rapidly, and the hemodynamic effects stabilize or decline (9, 11) . Direct microneurographic recordings of postganglionic muscle SNA in humans during nicotine administration have shown that, in addition to releasing catecholamines at the adrenergic nerve terminal, nicotine increases SNA (12) .
Heart rate variability (HRV), used as a measure of the relative, typically reciprocal, influence of sympathetic and vagal input to the heart, can be quantified using either time domain or frequency domain analyses, which provide comparable results. Depressed HRV first emerged as a powerful independent predictor of increased mortality following myocardial infarction (13) and signifies a shift in the sympathovagal balance toward sympathetic predominance, accompanied by decreased vagal activity.
Acute oral nicotine exposure in never-smokers acutely decreases HRV, consistent with a shift in the cardiac sympathovagal balance toward increased SNA (14) . The observations that during cigarette smoking (but not during sham smoking), plasma catecholamines, blood pressure, and heart rate increase acutely, and that acute hemodynamic effects are prevented by pharmacological adrenergic blockade support the notion that the acute cardiovascular effects of cigarette smoke are also mediated by the effects of nicotine on the autonomic nervous system (7).
The net effect of acute smoking and nicotine exposure on SNA depends on the relative balance between the direct sympathetic excitatory effects of tobacco smoke and the opposing sympathoinhibitory effects mediated by the baroreflex (Figure 1) . Paradoxically, early studies reported a sympathoinhibitory effect of acute tobacco smoke exposure in humans (15) (16) (17) (18) . Follow-up studies revealed that this apparent decrease in muscle SNA was mediated by the engagement of the baroreflex in response to the acute increase in blood pressure; if the increase in blood pressure was prevented pharmacologically, acute tobacco exposure increased muscle SNA (17, 18) . In older long-term smokers with relatively impaired baroreflex function, acute smoking produces an Smoking and the Autonomic Nervous System increase in muscle SNA due to a lack of baroreflex restraint. In contrast, in younger, healthy smokers whose negative baroreflex feedback loop is intact, acute smoking leads to a decrease in muscle SNA due to the activation of intact baroreflexes by the pressor effect of catecholamines released from nerve terminals by cigarette smoke. A significant correlation between baroreflex sensitivity and changes in muscle SNA during acute smoke exposure has been reported (19, 20) . Interestingly, in middle-age habitual smokers, acute smoking increases blood pressure to a greater extent in women compared with men (21) . One would then expect this augmented blood pressure response to reflexively suppress SNA to a greater degree in women, but SNA responses to acute smoking are similar in both sexes, consistent with an augmented sympathetic response to tobacco smoke exposure in women (21) . It is tempting to speculate that habitual smoking leads to greater baroreflex impairment in women than in men.
Indeed, smoking has been reported to confer a greater cardiovascular risk in female smokers than in male smokers (22) . In addition to older patients, patients with hypertension, heart failure, or diabetes also have impaired baroreflex function, perhaps illuminating one potential mechanism whereby smoking may increase cardiac risk in these vulnerable groups.
Similar to direct tobacco smoke exposure, secondhand smoke exposure also leads to sympathoexcitation. Secondhand smoke is composed of w15% exhaled mainstream smoke and w85% side-stream unfiltered smoke emerging from the tip of a burning cigarette, which contains even greater amounts of toxic compounds than does mainstream smoke (23) .
The acute effects of secondhand smoke on the autonomic nervous system in never-smokers have been evaluated using microneurography and HRV, and both techniques confirmed increased SNA during secondhand smoke exposure (24, 25) .
Nicotine is not the only component of cigarette smoke that mediates an increase in SNA; in shortterm studies, PM 2.5 also increased sympathetic tone (26) . Studies of the effects of air pollution on autonomic function helped to elucidate the role of PM 2.5 versus nicotine on SNA. Air pollution generated by the combustion of organic materials (specifically fossil fuels) is comparable in particle size and constituents to tobacco smoke, which is similarly generated by the combustion of organic materials (tobacco leaves), but with two major differences (27, 28) . First, the daily dose (in mg) of inhaled particulates from air pollution is generally several orders of magnitude less than is that of smoking a pack of cigarettes a day and is on par with that of a nonsmoker exposed to secondhand smoke when living with a smoker (27) .
It is important to remember that cardiovascular risk stemming from exposure to PM 2.5 has a steep doseresponse curve, so that even low levels of PM 2.5 exposure are potentially dangerous (27) . Second, air pollution does not contain nicotine. This latter difference permits inferences regarding the effects of PM 2.5 on the autonomic nervous system, independent of those of nicotine. As will be detailed later, acute 
BP ¼ blood pressure; ECC ¼ excitation-contraction coupling; HR ¼ heart rate; MVO2 ¼ myocardial oxygen consumption; VF ¼ ventricular fibrillation.
exposure to air pollution increases SNA in both animal models and in humans and is associated with increased cardiovascular risk (28, 29) , suggesting an important role for PM 2.5 .
In summary, acute cigarette smoke exposure in humans is associated with acute increases in blood pressure and heart rate, which have potentially detrimental effects in patients with heart failure, coronary artery disease, and arrhythmias (4, 6) . These acute hemodynamic effects are mediated by both increased catecholamine release and increased efferent SNA.
Because nicotine administration mimics the hemody- Fine particulate matter <2.5 mm in hydrodynamic diameter (PM 2.5 ) in tobacco smoke stimulates lung afferent C-fibers, either directly or through generation of oxidative stress, which then initiates neurogenic inflammation, further stimulating lung afferents. Lung afferents reflexively increase systemic (specifically cardiac) sympathetic nerve activity (SNA), which then increases cardiac inflammatory oxidation, further increasing cardiac SNA in a positive feedback loop. Nicotine in tobacco smoke stimulates nicotinic receptors in the rostral ventrolateral medulla, and decreases nitric oxide production centrally, thereby increasing central sympathetic outflow. Baroreflex suppression of sympathetic activation is attenuated in habitual smokers by 3 potential mechanisms: 1) neuroplasticity (PM 2.5 in tobacco smoke may induce neuroplasticity in the nucleus tractus solitarius, the first synapse of the baroreceptor afferents, thereby directly altering baroreflex responsiveness in smokers [34, 35] ); 2) oxidative stress (cigarette smoke, through particulate matter and/or nicotine, is known to generate oxidative stress [3] ; in animal models, free radicals attenuated baroreceptor activity, while oxyradical scavengers increased baroreceptor activity [36, 37] ); and 3) endothelial dysfunction (chronic active and passive tobacco exposure is associated with increased vascular stiffness; vascular reactivity mediated by nitric oxide is impaired [38, 39] ; thus, blood pressure fluctuations transmitted to the baroreceptors through changes in stretch of the vascular wall are dampened). NO ¼ nitric oxide; ROS ¼ reactive oxygen species; SNS ¼ sympathetic nervous system.
Middlekauff et al. In most studies of the baroreflex in smokers, they abstained from smoking for several hours, during which time nicotine levels and tolerance subsided. Middlekauff et al. Further, nicotine replacement therapy has been compared to tobacco cigarettes only for short durations; but in these short-term comparisons, it does not increase cardiac risk, even in patients with known coronary artery disease (65). Nonetheless, nicotine increases SNA, which should raise concern over long-term e-cigarette use, especially in young people who are nonsmokers.
In summary, the absence of combustion and organic substrates, and the knowledge that A i r p o l l u t i o n . As noted earlier, the constituents and size of PM 2.5 in air pollution (27) [28]).
Evidence supports the concept that adverse affects on the autonomic nervous system contribute to this increased cardiac risk (28, 29, 42, 47) . As reviewed earlier, in animal models, exposure to PM 2. 
